1
Postoperative Radiotherapy Plus Iressa or Radiotherapy Plus Cisplatin and Iressa for Advanced Head & Neck Cancer
Condition(s): Head and Neck Cancer Last Updated: September 21, 2010Completed
294 Clinical Trials for: GEFITINIB, Page 1 of 15
Hide Studies Not Seeking New Volunteers
2
Phase III Randomized, Placebo Controlled, Trial Of Docetaxel Versus Docetaxel Plus ZD1839 (Iressa, Gefitinib, NSC 715055) In Performance Status 2 Or Previously Treated Patients With Recurrent Or Metastatic Head And Neck Cancer
Condition(s): Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma; Recurrent Metastatic Squamous Neck Cancer With Occult Primary; Recurrent Salivary Gland Cancer; Recurrent Squamous Cell Carcinoma of the Hypopharynx; Recurrent Squamous Cell Carcinoma of the Larynx; Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity; Recurrent Squamous Cell Carcinoma of the Nasopharynx; Recurrent Squamous Cell Carcinoma of the Oropharynx; Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity; Recurrent Verrucous Carcinoma of the Larynx; Recurrent Verrucous Carcinoma of the Oral Cavity; Salivary Gland Squamous Cell Carcinoma; Stage IV Squamous Cell Carcinoma of the Hypopharynx; Stage IV Squamous Cell Carcinoma of the Nasopharynx; Stage IVA Salivary Gland Cancer; Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage IVA Squamous Cell Carcinoma of the Oropharynx; Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity; Stage IVA Verrucous Carcinoma of the Larynx; Stage IVA Verrucous Carcinoma of the Oral Cavity; Stage IVB Salivary Gland Cancer; Stage IVB Squamous Cell Carcinoma of the Larynx; Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage IVB Squamous Cell Carcinoma of the Oropharynx; Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity; Stage IVB Verrucous Carcinoma of the Larynx; Stage IVB Verrucous Carcinoma of the Oral Cavity; Stage IVC Salivary Gland Cancer; Stage IVC Squamous Cell Carcinoma of the Larynx; Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage IVC Squamous Cell Carcinoma of the Oropharynx; Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity; Stage IVC Verrucous Carcinoma of the Larynx; Stage IVC Verrucous Carcinoma of the Oral Cavity; Tongue Cancer; Untreated Metastatic Squamous Neck Cancer With Occult Primary Last Updated: January 8, 2013Completed
3
Study of Gefitinib Retreatment in Non-Small Cell Lung Cancer (NSCLC)
Condition(s): Carcinoma, Non-Small-Cell Lung Last Updated: January 22, 2013Completed
4
Hydroxychloroquine and Gefitinib to Treat Lung Cancer
Condition(s): Non-small Cell Lung Cancer Last Updated: March 27, 2012Recruiting
5
Gefitinib (Iressa) and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas
Condition(s): Brain and Central Nervous System Tumors Last Updated: June 13, 2011Completed
6
Phase II Study of Gefitinib Plus Nimotuzumab Versus Gefitinib in Non-small Cell Lung Cancer
Condition(s): Non Small Cell Lung Cancer (NSCLC) Last Updated: December 22, 2011Recruiting
7
High Dose Gefitinib for the Treatment of Carcinomatous Meningitis in Adult Patients With Non-Small Cell Lung Cancer and Known or Suspected EGFR Mutations
Condition(s): Non-Small Cell Lung Cancer Last Updated: April 25, 2013Completed
8
ZD1839 (Iressa) for Recurrent or Metastatic Squamous Cell Carcinoma of the Skin
Condition(s): Skin Cancer Last Updated: February 19, 2013Completed
9
Gefitinib in Treating Children With Refractory Solid Tumors
Condition(s): Unspecified Childhood Solid Tumor, Protocol Specific Last Updated: January 22, 2013Completed
10
Arimidex/Faslodex/Iressa Study: A Trial Using Arimidex, Faslodex and Iressa in Women With Breast Cancer
Condition(s): BREAST CANCER Last Updated: February 4, 2013Terminated
11
Study With Gefitinib in Combination With Olaparib (AZD2281) Versus Gefitinib Alone
Condition(s): Non Small Cell Lung Cancer Last Updated: March 8, 2013Recruiting
12
Gefitinib With or Without Simvastatin in Non-Small Cell Lung Cancer (NSCLC)
Condition(s): Lung Cancer Last Updated: September 15, 2011Completed
13
Gefitinib and Radiation Therapy in Treating Patients With Glioblastoma Multiforme
Condition(s): Adult Giant Cell Glioblastoma; Adult Glioblastoma; Adult Gliosarcoma Last Updated: May 6, 2013Completed
14
Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube Cancer
Condition(s): Ovarian Cancer; Peritoneal Neoplasms; Fallopian Tube Cancer Last Updated: October 18, 2012Active, not recruiting
15
Assess the Efficacy, Safety and Tolerability of Gefitinib (Iressa® 250mg) as Maintenance Therapy in Locally Advanced or Metastatic (Stage IIIB/IV) Non Small Cell Lung Cancer (NSCLC)
Condition(s): Non-small Cell Lung Cancer (NSCLC) Last Updated: August 20, 2012Completed
16
Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By Surgery
Condition(s): Esophageal Cancer Last Updated: August 15, 2011Terminated
17
Gefitinib 500mg Versus 250mg in Patients With NSCLC With Stable Disease After a Month Treatment of Gefitinib 250mg
Condition(s): Non-small Cell Lung Cancer Last Updated: February 12, 2012Active, not recruiting
18
A Study Of Nasopharyngeal Carcinoma (NPC) Treated With Celecoxib And ZD1839
Condition(s): Nasopharyngeal Carcinoma Last Updated: March 29, 2012Completed
19
Study Of SU011248 Plus Gefitinib (Iressa) In Patients With Advanced Renal Cell Carcinoma
Condition(s): Carcinoma, Renal Cell Last Updated: August 25, 2011Completed
20
A Study of IRESSA Treatment Beyond Progression in Addition to Chemotherapy Versus Chemotherapy Alone
Condition(s): Non-Small Cell Lung Cancer Last Updated: March 12, 2013Recruiting
